Virtus Pharmaceuticals, LLC is a Linden Capital Partners portfolio company. We are an asset light, fast growing, specialty pharmaceuticals company with global partnerships and access to multiple sales channels. The company was founded in 2011 and has a diverse portfolio of differentiated generics, brands, medical food, supplements, and Rx-OTC products across formulation types.
Virtus is focused on the marketing of generic and branded prescription and non-prescription products to pharmaceutical wholesalers, hospitals, specialty pharmacies and retailers across the U.S. We have a nimble business model that enables execution efficiency, supply chain flexibility, and rapid speed to market, which ideally positions Virtus to navigate market conditions.
We market approximately 40 product families in a variety of dosage forms including: injection, liquids, oral solids, and powders for solution. Our pipeline includes: injection, liquids, oral solids, powders for solution and semi-solids.
Virtus, based in Langhorne, PA with additional operations located in Bristol, PA, has an existing pipeline of late stage opportunities along with the capability to quickly execute on Business Development opportunities.